Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Evoke Pharma Inc (EVOK)

NASDAQ
Currency in USD
Disclaimer
0.4750
+0.0300(+6.74%)
Real-time Data

EVOK Comments

Reverse split
Super cheap, almost no competition and income continue to growth steady
Turning from debt to profit...!!! Going to double soon!!!
Should boom soon like a rocket...
bankrupt soon
the last call under usd3 !!!
soon usd 4
finally...quickly over usd 5
🐇
💸💵💰
💲
🐇
Too Much technicals. Can you Correlate this into financials ?
The bigger market for this drug is for off label use as an anti-emetic for postoperative patients having nausea and/or vomiting. The 2021 Medicare PQRS measures will include reducing outpatient admits for nausea and vomiting and the only currently available on intravenous or oral medications to treat patients at home after surgery are Compazine suppositories ( serious side reactions and people hate suppositories), or very expensive Zofran ODT ( oral dissolving tablets) that when you are already nauseated are not a great solution. The Intranasal route of Metoclopramide will be the most readily tolerated and should also be the most effective as loss of GI motility from general Anesthesia and from Narcotic pain medications is the primary cause of nausea and vomiting in the first few days post-op. This HUGE market will be driven by physicians looking for a means to ensure they capture the 10% Medicare hold back of PQRS.
buyers will be pleased
impatients are leaving.
$7?
Breaking $5 today ! Price target next 6 months ?
Here we gooooo
sellers will regret badly.
What is your target for this?
none.just right timing.
get ready people.
ready.
Slowly but surely ticking up.... Mfg and sales plan news in the pipeline I guess
Any news on this yet ? No momentum
Target price next 6-12 months ? Anyone ?
10
https://finance.yahoo.com/news/evoke-pharma-set-gain-170-025830940.html
Hope so. I bought at 3:43....
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.